PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40124C00132Characterizing albumin-bound nanoparticle DRUGS — University of Maryland, Baltimore

University of Maryland, Baltimore holds $67.5M across 131 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
University of Maryland, Baltimore
Recipient
Sep 29, 2026
PoP end
$460K
Obligated
$460K
Potential
334516
NAICS
R499
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs University of Maryland, Baltimore — $90

Contract facts

NONE
Contract number75F40124C00132
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentUniversity of Maryland, Baltimore
CAGE1B0S2
UEIZ9CRZKD42ZT1
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSCR499
Place of performanceBALTIMORE MD
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitationFDA BAA 24 00123
PoP startSep 12, 2024
PoP end (current)Sep 29, 2026
Obligated$460K
Current value$460K
Potential value$460K

CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR is a federal NONE award for Fda Office Of Acq Grant Svcs held by University of Maryland, Baltimore. Estimated value $460K ($460K obligated). Current period of performance ends Sep 29, 2026. Last award drew 1 bidder. Place of performance: BALTIMORE MD. Related solicitation FDA BAA 24 00123.

CHARACTERIZING ALBUMIN-BOUND NANOPARTICLE DRUGS USING WNMR

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 29, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

University of Maryland, Baltimore$67.5M obligated across 131 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($67.5M) · all agencies
Department of Health and Human Services (HHS)$52.9M · 78%Department of Veterans Affairs (VA)$8.9M · 13%Department of Defense (DOD)$3.8M · 6%Department of Transportation (DOT)$1.9M · 3%
Open full company profile

Related awards

Same incumbent
75N93019C00055
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE I…
$33.2M
Sep 15, 2026
75N90023C00013
CHOICE PLUS STUDY
$8.7M
Sep 29, 2026
75N90025P00808
25-008693 DATA SPECIALIST
$109K
Sep 29, 2026
FA238425CB046
SEE SECTION J, ATTACHMENT 1, STATEMENT OF WORK (SOW) TITLED, DEFINING LABORATORY DERANGEME…
$740K
Sep 30, 2026
36C24523C0013
IRB SERVICES
$600K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40124C00132?

75F40124C00132 (Characterizing albumin-bound nanoparticle DRUGS) is a Fda Office Of Acq Grant Svcs award with a potential value of $460K, currently held by University of Maryland, Baltimore. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40124C00132?

Fda Office Of Acq Grant Svcs awarded 75F40124C00132 to University of Maryland, Baltimore (potential $460K).

Who is the incumbent on 75F40124C00132?

University of Maryland, Baltimore is the incumbent with $67.5M across 131 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does University of Maryland, Baltimore’s 75F40124C00132 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40124C00132